Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy

D DeManno, W Elger, R Garg, R Lee, B Schneider… - Steroids, 2003 - Elsevier
Asoprisnil is a novel selective steroid receptor modulator that shows unique
pharmacodynamic effects in animal models and humans. Asoprisnil, its major metabolite …

Uses of progesterone in clinical practice.

MP Warren, S Shantha - International journal of fertility and women's …, 1999 - europepmc.org
Progesterone is the natural progestagen produced by the corpus luteum during the luteal
phase. It is absorbed when administered orally, but is greater than 90% metabolized during …

Effect of selective estrogen receptor modulators on reproductive tissues other than endometrium

SL Hendrix, SG McNEELEY - Annals of the New York Academy …, 2001 - Wiley Online Library
The objective of this paper is to review the published and unpublished knowledge of the
effect of selective estrogen receptor modulators on reproductive tissues other than …

BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies

A Wagenfeld, W Bone, W Schwede… - Human …, 2013 - academic.oup.com
STUDY QUESTION Does the novel progesterone receptor (PR) modulator BAY 1002670,
based on its preclinical pharmacological profile, offer a potential novel treatment option for …

Progestin therapy for maintaining amenorrhea

D DeZiegler, W Bologna, H Levine - US Patent App. 09/825,569, 2001 - Google Patents
0002 Progesterone is a naturally occurring steroid which is the main Steroid Secreted by
Women during their repro ductive years. This Steroid has been Studied extensively and has …

Progesterone antagonists: tumor-inhibiting potential and mechanism of action

H Michna, Y Nishino, G Neef, WL McGuire… - The Journal of Steroid …, 1992 - Elsevier
A new approach for the treatment of breast cancer could be the use of progesterone
antagonists. These compounds were originally developed for the inhibition of progesterone …

Selective estrogen receptor modulators (SERMS)

A Diez-Perez - Arquivos Brasileiros de Endocrinologia & Metabologia, 2006 - SciELO Brasil
Hormone receptors and, specifically, estrogen receptors were described about four decades
ago. For estrogens, there are two receptors, estrogen receptor alpha (ERalpha) and …

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects

FZ Stanczyk, JP Hapgood, S Winer… - Endocrine …, 2013 - academic.oup.com
The safety of progestogens as a class has come under increased scrutiny after the
publication of data from the Women's Health Initiative trial, particularly with respect to breast …

Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society: Retracted

North American Menopause Society - Menopause, 2003 - journals.lww.com
Objective: To create an evidence-based position statement regarding the role of
progestogen in postmenopausal hormone therapy (estrogen plus a progestogen, or EPT) for …

Selective estrogen receptor modulators

CCW Chan - Gynecological Drug Therapy, 2016 - taylorfrancis.com
Menopause brings about changes in the health of a postmenopausal woman that may have
a major impact in her life. Until recently, estrogens in various formulations and combinations …